Next Article in Journal
Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?
Next Article in Special Issue
Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients?
Previous Article in Journal
Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
Previous Article in Special Issue
Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(15), 3782; https://doi.org/10.3390/cancers14153782
Action Date Notes Link
article pdf uploaded. 3 August 2022 15:28 CEST Version of Record https://www.mdpi.com/2072-6694/14/15/3782/pdf-vor
article xml file uploaded 5 August 2022 05:37 CEST Original file -
article xml uploaded. 5 August 2022 05:37 CEST Update https://www.mdpi.com/2072-6694/14/15/3782/xml
article pdf uploaded. 5 August 2022 05:37 CEST Updated version of record https://www.mdpi.com/2072-6694/14/15/3782/pdf
article supplementary file uploaded. 5 August 2022 05:37 CEST - https://www.mdpi.com/2072-6694/14/15/3782#supplementary
article html file updated 5 August 2022 05:39 CEST Original file -
article html file updated 13 August 2022 05:28 CEST Update https://www.mdpi.com/2072-6694/14/15/3782/html
Back to TopTop